Auto3dMSC – Unravelling the challenges of automated 3D cultivation and characterization of mesenchymal stem cells

Auto3dMSC will result in the first technology/service for NON-INVASIVE SEMI-AUTOMATED development and growing of 3D mesenchymal stem cultures in the world. It will enable fast development and high volume production of human tissues to be used in preclinical research.
The project “Unravelling the challenges of automated 3D cultivation and characterization of mesenchymal stem cells – Auto3dMSC” is an interdisciplinary project of a consortium consisting of Austrian biotech start-up LifeTaq-Analytics GmbH and Biosistemika d.o.o.The goal of the project is to develop THE FIRST automated service for 3D cultivation and characterization of mesenchymal stem cells.
The project builds on the existing knowledge, capabilities, and solutions of both partners, merging and evolving them through the development in three fields of expertise: machine engineering, biotechnology, and information technology.
The final objective of the project is to develop two DISRUPTIVE COMMERCIAL products:
– Auto3dMSC SERVICES: cell cultivation service and protocol development service, both to enter the market 6-months to 1 year after the project completion.
– Auto3dMSC ROBOT: primarily considered as an ENABLER of Auto3dMSC Services and is due to commercial reasons planned to enter into commercialization later.
The main motivation behind the project is the successful market penetration and commercialization of Auto3dMSC SERVICES. We are targeting to promote a new MARKET NICHE OF CULTIVATION OF 3D MESENCHYMAL STEM CELLS by which we target to DISRUPT THE PROCESSES OF PRE-CLINICAL DEVELOPMENT OF NEW DRUGS AND THERAPIES.

BioSistemika’s role:

BioSistemika’s role in the project is to develop the complete software suite for the Auto3dMSC platform. In addition to providing a user interface to the robotized mesenchymal stem cell environment, the platform will provide automation to the complete cell culture process, from sample preparation to in vitro diagnostic screening, thereby significantly accelerating pre-clinical research of 3D tissue cultures.

The project is co-financed by the Republic of Slovenia and the European Union from the European Regional Development Fund. More information on the European cohesion program in Slovenia is available here: www.eu-skladi.si.